IL155277A0 - Identification of protein binding sites - Google Patents

Identification of protein binding sites

Info

Publication number
IL155277A0
IL155277A0 IL15527701A IL15527701A IL155277A0 IL 155277 A0 IL155277 A0 IL 155277A0 IL 15527701 A IL15527701 A IL 15527701A IL 15527701 A IL15527701 A IL 15527701A IL 155277 A0 IL155277 A0 IL 155277A0
Authority
IL
Israel
Prior art keywords
segment
protein
nucleic acid
discontinuous
identification
Prior art date
Application number
IL15527701A
Other languages
English (en)
Original Assignee
Pepscan Systems Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pepscan Systems Bv filed Critical Pepscan Systems Bv
Publication of IL155277A0 publication Critical patent/IL155277A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
IL15527701A 2000-10-11 2001-10-10 Identification of protein binding sites IL155277A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203518A EP1197755A1 (fr) 2000-10-11 2000-10-11 Identification de sites de liaison de protéines
PCT/NL2001/000744 WO2002031510A1 (fr) 2000-10-11 2001-10-10 Identification de sites de liaison de proteines

Publications (1)

Publication Number Publication Date
IL155277A0 true IL155277A0 (en) 2003-11-23

Family

ID=8172123

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15527701A IL155277A0 (en) 2000-10-11 2001-10-10 Identification of protein binding sites
IL155277A IL155277A (en) 2000-10-11 2003-04-07 Identification of protein binding sites

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155277A IL155277A (en) 2000-10-11 2003-04-07 Identification of protein binding sites

Country Status (14)

Country Link
US (2) US7972993B2 (fr)
EP (2) EP1197755A1 (fr)
JP (2) JP2004511780A (fr)
AT (1) ATE411526T1 (fr)
AU (2) AU1109902A (fr)
CA (1) CA2424611C (fr)
CY (1) CY1110101T1 (fr)
DE (1) DE60136202D1 (fr)
DK (1) DK1325340T3 (fr)
ES (1) ES2317941T3 (fr)
IL (2) IL155277A0 (fr)
NZ (1) NZ524874A (fr)
PT (1) PT1325340E (fr)
WO (1) WO2002031510A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225254A1 (en) * 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
US5959087A (en) * 1989-08-07 1999-09-28 Peptide Technology, Ltd. Tumour necrosis factor binding ligands
EP0486526B2 (fr) 1989-08-07 2001-03-07 Peptech Limited Ligands de liaison du facteur de necrose de tumeurs
EP1197755A1 (fr) 2000-10-11 2002-04-17 Pepscan Systems B.V. Identification de sites de liaison de protéines
US7504364B2 (en) * 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
EP1388544A1 (fr) * 2002-07-31 2004-02-11 D. Collen Research Foundation vzw Anticorps anti-idiotypes dirigés contre l'inhibiteur de facteur VIII et leurs applications
US20040137481A1 (en) * 2002-09-16 2004-07-15 Receptors Llc Artificial receptor building blocks, components, and kits
US20050037381A1 (en) * 2002-09-16 2005-02-17 Receptors Llc Artificial receptors, building blocks, and methods
US20050136483A1 (en) * 2003-09-03 2005-06-23 Receptors Llc Nanodevices employing combinatorial artificial receptors
WO2005003326A2 (fr) * 2003-03-28 2005-01-13 Receptors Llc. Recepteurs artificiels comprenant des blocs de construction immobilises de maniere reversible et procedes
US7469076B2 (en) * 2003-09-03 2008-12-23 Receptors Llc Sensors employing combinatorial artificial receptors
US20060057625A1 (en) * 2002-09-16 2006-03-16 Carlson Robert E Scaffold-based artificial receptors and methods
US20060051802A1 (en) * 2002-09-16 2006-03-09 Receptors Llc Artificial receptors, building blocks, and methods
US20050170385A1 (en) * 2002-09-16 2005-08-04 Receptors Llc Artificial receptors including gradients
US7736909B2 (en) 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
EP1452868A2 (fr) 2003-02-27 2004-09-01 Pepscan Systems B.V. Procédé pour sélectionner un médicament d'intérêt potentiel
US7365154B2 (en) 2003-06-23 2008-04-29 Centocor, Inc. Peptides antagonistic to an anti-angiogenic antibody and uses therefor
WO2006028930A2 (fr) * 2004-09-03 2006-03-16 Receptors Llc Recepteurs artificiels combinatoires contenant des elements constitutifs de liaison sur des squelettes
WO2006029383A2 (fr) * 2004-09-11 2006-03-16 Receptors Llc Recepteurs artificiels combinatoires comprenant des blocs structurels peptidiques
US20100004134A1 (en) * 2007-01-12 2010-01-07 Lawrence Horowitz Combinatorial libraries of conformationally constrained polypeptide sequences
AU2010211438B2 (en) 2009-02-06 2016-04-14 Academisch Ziekenhuis Maastricht Truncated cystine-knot proteins
CA2764153C (fr) 2009-06-02 2021-07-27 The Board Of Regents Of The University Of Texas System Identification de petites molecules reconnues par des anticorps chez des sujets atteints de maladies neurodegeneratives
WO2011047257A1 (fr) 2009-10-16 2011-04-21 The Board Of Regents Of The University Of Texas System Compositions et procédés de production de banques de peptoïdes cycliques
CA2800311A1 (fr) * 2010-05-11 2011-11-17 Aveo Pharmaceuticals, Inc. Anticorps anti-fgfr2
EP3351641A1 (fr) 2011-04-08 2018-07-25 Tufts Medical Center, Inc. Conception et utilisation de pepducine
KR20140125351A (ko) 2011-11-23 2014-10-28 이제니카 바이오테라퓨틱스, 인크. 항-cd98 항체 및 이의 사용 방법
EP2812344A4 (fr) 2012-02-07 2015-10-28 Vibrant Holdings Llc Substrats, réseaux de peptides et procédés
US10006909B2 (en) 2012-09-28 2018-06-26 Vibrant Holdings, Llc Methods, systems, and arrays for biomolecular analysis
AU2013329311A1 (en) 2012-10-09 2015-04-30 Igenica Biotherapeutics, Inc. Anti-C16orf54 antibodies and methods of use thereof
US10286376B2 (en) 2012-11-14 2019-05-14 Vibrant Holdings, Llc Substrates, systems, and methods for array synthesis and biomolecular analysis
CA2923379C (fr) 2013-02-15 2023-01-03 Vibrant Holdings, Llc Methodes et compositions de reseaux de detection d'electrochimioluminescence amplifiee
EP2767549A1 (fr) 2013-02-19 2014-08-20 Adienne S.A. Anticorps anti-CD26 et leurs utilisations
WO2015097077A2 (fr) 2013-12-27 2015-07-02 F. Hoffmann-La Roche Ag Découverte systémique, maturation et extension de peptides de liaison aux protéines
PL3097122T3 (pl) 2014-01-24 2020-10-19 Ngm Biopharmaceuticals, Inc. Przeciwciała wiążące domenę 2 beta klotho oraz sposoby ich stosowania
US10822604B2 (en) 2014-05-02 2020-11-03 Morphosys Ag Peptide libraries
CA2960655C (fr) 2014-09-10 2024-03-19 Vibrant Holdings, Llc Microreseaux de peptides et nouveaux biomarqueurs pour la maladie coeliaque
EP3286569B1 (fr) 2015-04-20 2020-07-22 H. Hoffnabb-La Roche Ag Liants peptidiques spécifiques aux protéines identifiés par un processus systémique de découverte, de maturation et d'extension
JP6328851B2 (ja) * 2015-06-24 2018-05-23 Ｊｃｒファーマ株式会社 血液脳関門を通過する抗ヒトトランスフェリン受容体抗体
EP3315515A4 (fr) 2015-06-24 2019-06-05 JCR Pharmaceuticals Co., Ltd. Protéine hybride contenant un bdnf
JP6869987B2 (ja) 2015-09-01 2021-05-12 アジェナス インコーポレイテッド 抗ｐｄ−１抗体及びその使用方法
US11091533B2 (en) 2015-11-13 2021-08-17 Oasis Pharmaceuticals, LLC Protease-activated receptor-2 modulators
KR102543118B1 (ko) 2016-05-27 2023-06-14 아게누스 인코포레이티드 항-tim-3 항체 및 이의 사용 방법
CA3037380A1 (fr) 2016-10-11 2018-04-19 Agenus Inc. Anticorps anti-lag-3 et leurs procedes d'utilisation
AU2017373944B2 (en) 2016-12-07 2022-02-03 Agenus Inc. Anti-CTLA-4 antibodies and methods of use thereof
AR110586A1 (es) 2016-12-26 2019-04-10 Japan Chem Res Anticuerpo de receptor antitransferrina humana que penetra la barrera hematoencefálica
BR112019017241A2 (pt) 2017-04-13 2020-04-14 Agenus Inc anticorpos anti-cd137 e métodos de uso dos mesmos
DK3618863T3 (da) 2017-05-01 2023-08-21 Agenus Inc Anti-tigit-antistoffer og fremgangsmåder til anvendelse deraf
WO2018218250A2 (fr) 2017-05-26 2018-11-29 Vibrant Holdings, Llc Composés photoactifs et procédés de détection et de séquençage de biomolécules
SG11201913137VA (en) 2017-07-11 2020-01-30 Compass Therapeutics Llc Agonist antibodies that bind human cd137 and uses thereof
US11718679B2 (en) 2017-10-31 2023-08-08 Compass Therapeutics Llc CD137 antibodies and PD-1 antagonists and uses thereof
US11851497B2 (en) 2017-11-20 2023-12-26 Compass Therapeutics Llc CD137 antibodies and tumor antigen-targeting antibodies and uses thereof
WO2020033925A2 (fr) 2018-08-09 2020-02-13 Compass Therapeutics Llc Anticorps qui se lient à cd277 et leurs utilisations
AU2019379576A1 (en) 2018-11-13 2021-06-03 Compass Therapeutics Llc Multispecific binding constructs against checkpoint molecules and uses thereof
JP7539897B2 (ja) 2019-01-16 2024-08-26 コンパス セラピューティクス リミテッド ライアビリティ カンパニー ヒトｃｄ１３７に結合する抗体の製剤およびその使用
TW202122420A (zh) 2019-08-30 2021-06-16 美商艾吉納斯公司 抗ｃｄ９６抗體及其使用方法
WO2021080682A1 (fr) 2019-10-24 2021-04-29 Massachusetts Institute Of Technology Anticorps monoclonaux qui se lient au cd161 humain et leurs utilisations
RU2743316C1 (ru) * 2020-08-14 2021-02-17 Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий Способ идентификации участков связывания белковых комплексов
WO2023028501A1 (fr) 2021-08-23 2023-03-02 Immunitas Therapeutics, Inc. Anticorps anti-cd161 et leurs utilisations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5368712A (en) * 1989-11-02 1994-11-29 Synporin Technologies, Inc. Biologically mimetic synthetic ion channel transducers
US6040423A (en) * 1990-08-31 2000-03-21 Gsellschaft Fur Biotechnologische Forschung Mbh (Gbf) Process for synthesis of peptides
TW199152B (fr) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
US5474895A (en) * 1990-11-14 1995-12-12 Siska Diagnostics Inc. Non-isotopic detection of nucleic acids using a polystyrene support-based sandwich hybridization assay and compositions useful therefor
JPH04204379A (ja) 1990-11-30 1992-07-24 Hitachi Ltd 生体成分分析法
NL9101953A (nl) 1991-11-21 1993-06-16 Seed Capital Investments Testinrichting omvattende een plaat met een veelvoud van putjes met een bijbehorende doseerinrichting, alsmede een kit die deze inrichtingen omvat en toepassing van de inrichtingen.
US5824483A (en) * 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
WO1996009411A1 (fr) * 1994-09-21 1996-03-28 Cytogen Corporation Peptides de liaison d'antigenes (abtides) provenant de banques de peptides
US5885577A (en) * 1994-09-21 1999-03-23 Cytogen Corporation Antigen binding peptides (abtides) from peptide libraries
US5940447A (en) 1996-08-30 1999-08-17 Motorola, Inc. Wireless powered communication device using power signal sampling and method
US6306643B1 (en) 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6461812B2 (en) * 1998-09-09 2002-10-08 Agilent Technologies, Inc. Method and multiple reservoir apparatus for fabrication of biomolecular arrays
JP4024442B2 (ja) 1998-12-15 2007-12-19 富士フイルム株式会社 試験片と生体由来物質の定量方法及び装置
US6642353B1 (en) * 1999-03-17 2003-11-04 Chugai Seiyaku Kabushiki Kaisha Peptide ligands for the erythropoietin receptor
EP1197755A1 (fr) 2000-10-11 2002-04-17 Pepscan Systems B.V. Identification de sites de liaison de protéines

Also Published As

Publication number Publication date
EP1197755A1 (fr) 2002-04-17
PT1325340E (pt) 2009-01-07
US20120190564A1 (en) 2012-07-26
JP2004511780A (ja) 2004-04-15
AU2002211099B2 (en) 2007-01-11
EP1325340A1 (fr) 2003-07-09
WO2002031510A1 (fr) 2002-04-18
US20030228605A1 (en) 2003-12-11
ES2317941T3 (es) 2009-05-01
JP2009058517A (ja) 2009-03-19
EP1325340B1 (fr) 2008-10-15
CA2424611A1 (fr) 2002-04-18
AU1109902A (en) 2002-04-22
JP4808756B2 (ja) 2011-11-02
US7972993B2 (en) 2011-07-05
CA2424611C (fr) 2011-01-25
DE60136202D1 (de) 2008-11-27
DK1325340T3 (da) 2009-02-16
NZ524874A (en) 2004-09-24
IL155277A (en) 2011-07-31
CY1110101T1 (el) 2015-01-14
ATE411526T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
IL155277A0 (en) Identification of protein binding sites
CY1108962T1 (el) Συνθεση μεταμεριδιου
He et al. Recent advances in the study of biomolecular interactions by capillary electrophoresis
AU2006273834B2 (en) Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-1-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
ATE446511T1 (de) Neue fusionsproteine und molekulare bindungsassays
ATE300051T1 (de) Test zum nachweis von prionen-proteinen die in einer mit krankheit assoziierten konformationen vorliegen
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
US20100331199A1 (en) Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture
NO960924L (no) Analysesett
DE69628194D1 (de) Verfahren zum nachweis von verbindungen die bestimmte zielmoleküle binden
WO2003002724A3 (fr) Proteines, zones de proteines pouvant etre ciblees et analyse de cibles servant a la composition chimique de medicaments
WO1997043301A3 (fr) Identification de membres de bibliotheques combinatoires par spectrometrie de masse
DE60038677D1 (de) Verfahren zum nachweis von proteinen, die miteinander interagieren
Lehman et al. Image subtraction approach to screening one-bead-one-compound combinatorial libraries with complex protein mixtures
WO2003010536A3 (fr) Analogues tnf-alpha et optimisation principale
Zeng et al. Improved CILAT reagents for quantitative proteomics
US20020045277A1 (en) Process for detecting biological molecules
WO2005016230A3 (fr) Evaluation de signatures proteiques
Hoffmann et al. Transformation of a biologically active peptide into peptoid analogs while retaining biological activity
Seo et al. Mass-balanced 1H/2H isotope dipeptide tag for simultaneous protein quantitation and identification
Liu Characterizing SH2 domain specificity and network interactions using SPOT peptide arrays
WO2003016479A3 (fr) Recepteurs excitateurs de la glycine et procedes associes
DE69405989D1 (de) Hippurikasegen
WO2002074927A3 (fr) Identification haute precision de proteines
BR0115752A (pt) Uso de proteìnas com ligação cruzada de forma covalente intramolecular como parceiras na ligação em imunoensaios